fda covid - Search News

Order byBest matchMost fresh

FDA will OK updated COVID vaccines for some

What to know about the FDA plan to restrict COVID vaccines

In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only to people over 65 years old or those with an underlying health condition.

· 11m · on MSN

· 1h · on MSN

Who can get updated COVID vaccines this fall? FDA tightening rules

· 2h

FDA’s new approach raises questions about fall COVID vaccine availability

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 13h

· 14h

F.D.A. Poised to Restrict Access to Covid Vaccines

· 15h

New Trump Vaccine Policy Limits Access To COVID Shots

FDA plans to limit COVID vaccine to only high-risk people. Florida cases, deaths in 2025

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 20h

· 17h

New FDA rule could delay Covid vaccine rollout for healthy adults and kids

· 22h

FDA sets new COVID booster guidelines for healthy adults under 65

17hon MSN

FDA may limit future Covid-19 shots to older people and those at risk of serious infection

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.

19hon MSN

Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

Fierce Biotech2h

Moderna withdraws FDA filing for flu/COVID combination vaccine, plans resubmission with efficacy data

Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win approval in adults aged 50 and older in November 2025. However, at the start of May, Moderna pushed back the expected approval date to 2026 after the FDA asked to see phase 3 efficacy before making a decision on authorization.

1don MSN

FDA to Unveil Covid Shot Policy as RFK Jr. Eyes More Tests

President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.